CN110074291A - Purposes of the probiotics in the child health care product or drink of preparation strengthen immunity - Google Patents
Purposes of the probiotics in the child health care product or drink of preparation strengthen immunity Download PDFInfo
- Publication number
- CN110074291A CN110074291A CN201910407579.6A CN201910407579A CN110074291A CN 110074291 A CN110074291 A CN 110074291A CN 201910407579 A CN201910407579 A CN 201910407579A CN 110074291 A CN110074291 A CN 110074291A
- Authority
- CN
- China
- Prior art keywords
- parts
- probiotics
- health care
- drink
- care product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006041 probiotic Substances 0.000 title claims abstract description 40
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 40
- 230000036541 health Effects 0.000 title claims abstract description 30
- 230000036039 immunity Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 240000001046 Lactobacillus acidophilus Species 0.000 claims abstract description 17
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims abstract description 17
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims abstract description 16
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims abstract description 4
- 229940009289 bifidobacterium lactis Drugs 0.000 claims abstract description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 15
- 239000000843 powder Substances 0.000 claims description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 7
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 7
- 235000021014 blueberries Nutrition 0.000 claims description 7
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 6
- 230000001580 bacterial effect Effects 0.000 claims description 6
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 5
- 229920002907 Guar gum Polymers 0.000 claims description 5
- 240000007049 Juglans regia Species 0.000 claims description 5
- 235000009496 Juglans regia Nutrition 0.000 claims description 5
- 229920002752 Konjac Polymers 0.000 claims description 5
- 240000000249 Morus alba Species 0.000 claims description 5
- 235000008708 Morus alba Nutrition 0.000 claims description 5
- 239000004376 Sucralose Substances 0.000 claims description 5
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 5
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 5
- 235000004634 cranberry Nutrition 0.000 claims description 5
- 235000013312 flour Nutrition 0.000 claims description 5
- 239000000665 guar gum Substances 0.000 claims description 5
- 229960002154 guar gum Drugs 0.000 claims description 5
- 235000010417 guar gum Nutrition 0.000 claims description 5
- BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 claims description 5
- 239000004302 potassium sorbate Substances 0.000 claims description 5
- 229940069338 potassium sorbate Drugs 0.000 claims description 5
- 235000010241 potassium sorbate Nutrition 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 5
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 claims description 5
- 235000019408 sucralose Nutrition 0.000 claims description 5
- 235000020234 walnut Nutrition 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 4
- 229930003268 Vitamin C Natural products 0.000 claims description 4
- 235000019154 vitamin C Nutrition 0.000 claims description 4
- 239000011718 vitamin C Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000007902 hard capsule Substances 0.000 claims description 2
- 239000003094 microcapsule Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000007901 soft capsule Substances 0.000 claims description 2
- 240000001717 Vaccinium macrocarpon Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 12
- 241000894006 Bacteria Species 0.000 abstract description 9
- 230000000968 intestinal effect Effects 0.000 abstract description 6
- 210000000936 intestine Anatomy 0.000 abstract description 6
- 241000186016 Bifidobacterium bifidum Species 0.000 abstract description 4
- 206010010774 Constipation Diseases 0.000 abstract description 4
- 206010012735 Diarrhoea Diseases 0.000 abstract description 4
- 244000005700 microbiome Species 0.000 abstract description 4
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 230000035755 proliferation Effects 0.000 abstract description 4
- 210000002784 stomach Anatomy 0.000 abstract description 4
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract description 3
- 230000003712 anti-aging effect Effects 0.000 abstract description 3
- 229940002008 bifidobacterium bifidum Drugs 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract description 3
- 230000036737 immune function Effects 0.000 abstract description 3
- 244000052769 pathogen Species 0.000 abstract description 3
- 244000000010 microbial pathogen Species 0.000 abstract description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 240000005373 Panax quinquefolius Species 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 244000291414 Vaccinium oxycoccus Species 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- 241000186000 Bifidobacterium Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 240000008397 Ganoderma lucidum Species 0.000 description 2
- 235000001637 Ganoderma lucidum Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 2
- 241000241413 Propolis Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 108010038836 acidolin Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000021028 berry Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940069949 propolis Drugs 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 241000304886 Bacilli Species 0.000 description 1
- 241000193755 Bacillus cereus Species 0.000 description 1
- 241000193749 Bacillus coagulans Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000193171 Clostridium butyricum Species 0.000 description 1
- 241000305071 Enterobacterales Species 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 239000009636 Huang Qi Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000077233 Vaccinium uliginosum Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000001745 anti-biotin effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940054340 bacillus coagulans Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 244000005709 gut microbiome Species 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- CEIZFXOZIQNICU-UHFFFAOYSA-N tenuazonic acid Chemical compound CCC(C)C1NC(=O)C(C(C)=O)=C1O CEIZFXOZIQNICU-UHFFFAOYSA-N 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
Abstract
The present invention provides a kind of purposes of probiotics in the child health care product or drink of preparation strengthen immunity, is related to probiotics novel medical use field.Purposes of the probiotics of the present invention in the child health care product or drink of preparation strengthen immunity, probiotics includes bifidobacterium lactis, lactobacillus acidophilus, and newborn Bifidobacterium Bifidum can safeguard enteron aisle normal bacteria colony balance, inhibit the growth of pathogen, prevent constipation, diarrhea and gastrointestinal disorders etc.；Enhance human immunologic function, prevents the side effect of antibiotic, anti-aging is promoted longevity；Lactobacillus acidophilus can coordinating intestines and stomach Tiny ecosystem, adjust intestinal flora balance, inhibit enteron aisle undesirable microorganism proliferation, lactobacillus acidophilus to pathogenic microorganisms have twisting effect.
Description
Technical field
The present invention relates to probiotics novel medical uses more particularly to probiotics in the child health care product for preparing strengthen immunity
Or the application in drink, belong to probiotics novel medical use field.
Background technique
Currently, eating strong word product by the state for the strengthen immunity ratified and have 1976 on the market.But wherein, mostly
It is all using ganoderma lucidum, propolis, American Ginseng, ginseng, protein, probiotics, the materials such as Radix Astragali or raw material are declared.These materials some
It is traditional food, some study on mechanism are not thorough.And children are much not particularly suited for, and such as ganoderma lucidum, American Ginseng etc., discomfort
For some especial patients, such as propolis, eat at high cost, and effect has no obvious.
Probiotics (Probiotics) is a kind of work to be played a role by improving host intestine microbial flora balance
Property microorganism, is the important physiology bacterium of human body intestinal canal, can promote the ecological balance of gut microflora, there is improvement enterobacteriaceae
Group structure promotes the important physiological functions such as the proliferation of beneficial bacterium in enteron aisle, the growth for inhibiting harmful bacteria, currently with probiotics system
At the probiotics preparations such as drug, health care product or drink be mainly used for diarrhea, constipation and abdomen caused by treating intestinal bacilli illness
Swollen equal bowel symptoms, common probiotics strain have clostridium butyricum, bacillus coagulans, Bifidobacterium, lactobacillus, withered grass gemma
Bacillus, bacillus licheniformis, bacillus cereus, enterococcus and certain streptococcus etc..
Summary of the invention
In view of the shortcomings of the prior art, the present invention provides a kind of probiotics in the child health care product or drink of preparation strengthen immunity
Purposes in product.
In order to achieve the above object, technical solution of the present invention is achieved by the following technical programs:
Purposes of the probiotics in the child health care product or drink of preparation strengthen immunity.
Preferably, the probiotics includes bifidobacterium lactis, lactobacillus acidophilus.
Purposes of the probiotics in the child health care product of preparation strengthen immunity.
Purposes of the probiotics in children's drink of preparation strengthen immunity.
Preferably, the dosage form of the health care product includes: tablet, electuary, pill, emulsion, granule, soft capsule, hard capsule
Or microcapsules.
A kind of the child health care product or drink of strengthen immunity, the health care product or drink include the original of following parts by weight
Material: 72.3-80 parts of pure water, 0.01-0.08 parts of probiotics bacterial powder, 0.5-2.5 parts of walnut peptide, 0.01-0.08 parts of konjaku flour, mulberry
0.5-3 parts of sorosis powder, 0.2-0.4 parts of DL-malic acid, 0.12-0.3 parts of guar gum, 0.02-0.08 parts of potassium sorbate, vitamin
C0.07-0.2 parts, 0.008-0.05 parts of Sucralose, 12-18 parts of blueberry inspissated juice, 10-16 parts of Cranberry inspissated juice, edible perfume
It is 0.062-0.2 parts smart.
The present invention provides a kind of purposes of probiotics in the child health care product or drink of preparation strengthen immunity, and existing
Technology is compared to advantage:
Purposes of the probiotics of the present invention in the child health care product or drink of preparation strengthen immunity, probiotics include that cream is double
Discrimination bacillus, lactobacillus acidophilus, newborn Bifidobacterium Bifidum can safeguard enteron aisle normal bacteria colony balance, inhibit the growth of pathogen, prevent
Only constipation, diarrhea and gastrointestinal disorders etc.；Enhance human immunologic function, prevents the side effect of antibiotic, anti-aging is promoted longevity；
Lactobacillus acidophilus can coordinating intestines and stomach Tiny ecosystem, adjust intestinal flora balance, inhibit enteron aisle undesirable microorganism proliferation.Acidophilus cream
Bacillus has twisting effect to pathogenic microorganisms.
Detailed description of the invention
Fig. 1 is the preparation flow figure of blueberry inspissated juice of the present invention；
Fig. 2 is the preparation flow figure of Cranberry inspissated juice of the present invention.
In figure, Normal juice enzymatic hydrolysis is to be warming up to 50 DEG C of 1 hours of enzymatic hydrolysis, and the sterilization temperature of UHT sterilization: 95-105 ° continues 90
Second.
Specific embodiment
In order to make the object, technical scheme and advantages of the embodiment of the invention clearer, below with reference to the embodiment of the present invention pair
Technical solution in the embodiment of the present invention is clearly and completely described, it is clear that described embodiment is a part of the invention
Embodiment, instead of all the embodiments.Based on the embodiments of the present invention, those of ordinary skill in the art are not making wound
Every other embodiment obtained under the premise of the property made labour, shall fall within the protection scope of the present invention.
The storage requirement of Cranberry inspissated juice: the product that do not break a seal should be stored in 5 ° or less freezers and can keep 12 months.
The product in Kaifeng must necessarily be placed in -18 DEG C or less freezings.Must not with it is toxic, harmful, have peculiar smell, volatile, perishable article it is mixed
It deposits.
Blueberry inspissated juice storage requirement: the product that do not break a seal should be stored in 5 ° or less freezers and can keep 12 months.Kaifeng
Product must necessarily be placed in -18 DEG C or less freezings.Must not with it is toxic, harmful, have peculiar smell, volatile, perishable article is mixed deposits.
Probiotic powder (bifidobacterium lactis, lactobacillus acidophilus)
Lactobacillus acidophilus (Lactobacillusacidophilus, abbreviation A) and Bacillus bifidus
The leavening (probiotics) of (Bifidobacterium, abbreviation B) mixing composition.Food of the intake containing both viable bacterias offsets
It is beneficial to change organ, gastrointestinal dysfunction especially is caused to the crowd of gastrointestinal dysfunction and some Long-term Oral antibiotic
, so the ratio with probiotics in good nutrition and health care human body intestinal canal is higher, micro-ecological environment is better, and enteron aisle is got over
It is aobvious young vibrant.The health of enteron aisle is not only embodied in that digestion and absorption is good, stool is normal and not easy infection intestines problem；To complete
For body, sufficient, great-hearted probiotics reduces the generation of vivotoxin, alleviates liver by inhibiting various harmful bacterias
Dirty removing toxic substances burden；After Bifidobacterium and lactobacillus acidophilus are fermented in enteron aisle, also can produce lactic acid and acetic acid, can improve calcium, phosphorus,
The utilization rate of iron promotes the absorption of iron and vitamin D, generates vitamin K and vitamin B, can also reduce the absorption of cholesterol,
And the injury of Radiation On Human body can be reduced.
The effect of newborn Bifidobacterium Bifidum: maintenance enteron aisle normal bacteria colony balance inhibits the growth of pathogen, prevents constipation,
Diarrhea and gastrointestinal disorders etc.；It is antitumor；Vitamin, amino acid are synthesized in enteron aisle and improve absorption of the body to calcium ion；Drop
Low Blood Cholesterol is horizontal, prevents and treats hypertension；Improve the resistance to lactose of product, improves digestibility；Enhance human immunologic function,
Prevent the side effect of antibiotic, anti-aging is promoted longevity；Enhance the non-specific and specific immune response of body；Control endogenous toxic material
The effect of plain mass formed by blood stasis；Host is improved to the tolerance of radioactive ray.
The effect of lactobacillus acidophilus
Coordinating intestines and stomach Tiny ecosystem: survival rate can generally reach 80% to lactobacillus acidophilus under one's belt, and not only under one's belt, it is still
Main probiotics energy stomach, intestines in human small intestine be the same as supporting, it is ensured that activity of the viable bacteria in enteron aisle.
Tolerance: although viable count is 0 after lactobacillus acidophilus La-IM2 is acted on 3 hours in pH1.5, in other works
Viable count under the conditions of is in 108CFU/mL or more, it was demonstrated that tolerance of bacterial strain under the conditions of simulation hydrochloric acid pH is preferable, can
To play beneficial function by the low in acidity environment of gastric juice.
Health-care effect: adjustment intestinal flora balance inhibits the proliferation of enteron aisle undesirable microorganism.Lactobacillus acidophilus is micro- to causing a disease
Biology has twisting effect.Lactobacillus acidophilus can secrete antibiotin substance (acidolin (acidolin), bacillus acidophilus
Element (acidophilin), lactein (1aetocidon)), the antagonism that pathogenic entero becteria is generated.
Embodiment 1:
Purposes of the present embodiment probiotics in the child health care product or drink of preparation strengthen immunity, wherein enhancing is exempted from
The child health care product or drink of epidemic disease power, which is characterized in that the health care product or drink include the raw material of following parts by weight: pure
80 parts of water, 0.08 part of probiotics bacterial powder, 2.5 parts of walnut peptide, 0.08 part of konjaku flour, 3 parts of mulberry powder, 0.4 part of DL-malic acid,
0.3 part of guar gum, 0.08 part of potassium sorbate, 0.2 part of vitamin C, 0.05 part of Sucralose, 12-18 parts of blueberry inspissated juice, it is climing more
16 parts of certain kind of berries inspissated juice, 0.2 part of edible essence.
Embodiment 2:
Purposes of the present embodiment probiotics in the child health care product or drink of preparation strengthen immunity, wherein enhancing is exempted from
The child health care product or drink of epidemic disease power, which is characterized in that the health care product or drink include the raw material of following parts by weight: pure
72.3 parts of water, 0.01 part of probiotics bacterial powder, 0.5 part of walnut peptide, 0.01 part of konjaku flour, 0.5 part of mulberry powder, DL-malic acid 0.2
Part, 0.12 part of guar gum, 0.02 part of potassium sorbate, 0.07 part of vitamin C, 0.008 part of Sucralose, 12 parts of blueberry inspissated juice,
10 parts of Cranberry inspissated juice, 0.062 part of edible essence.
Embodiment 3:
Purposes of the present embodiment probiotics in the child health care product or drink of preparation strengthen immunity, wherein enhancing is exempted from
The child health care product or drink of epidemic disease power, which is characterized in that the health care product or drink include the raw material of following parts by weight: pure
76 parts of water, 0.05 part of probiotics bacterial powder, 1.5 parts of walnut peptide, 0.05 part of konjaku flour, 2 parts of mulberry powder, 0.3 part of DL-malic acid,
0.21 part of guar gum, 0.05 part of potassium sorbate, 0.13 part of vitamin C, 0.025 part of Sucralose, 15 parts of blueberry inspissated juice, it is climing more
13 parts of certain kind of berries inspissated juice, 0.13 part of edible essence.
It should be noted that the above embodiments are merely illustrative of the technical solutions of the present invention, rather than its limitations；Although ginseng
According to previous embodiment, invention is explained in detail, those skilled in the art should understand that: it still can be with
It modifies the technical solutions described in the foregoing embodiments or equivalent replacement of some of the technical features；And
These are modified or replaceed, the spirit and model of technical solution of various embodiments of the present invention that it does not separate the essence of the corresponding technical solution
It encloses.
Claims (6)
1. purposes of the probiotics in the child health care product or drink of preparation strengthen immunity.
2. purposes according to claim 1, which is characterized in that the probiotics includes bifidobacterium lactis, lactobacillus acidophilus.
3. purposes of the probiotics in the child health care product of preparation strengthen immunity.
4. purposes of the probiotics in children's drink of preparation strengthen immunity.
5. purposes according to claim 3, which is characterized in that the dosage form of the health care product include: tablet, electuary, pill,
Emulsion, granule, soft capsule, hard capsule or microcapsules.
6. the child health care product or drink of a kind of strengthen immunity, which is characterized in that the health care product or drink include following
The raw material of parts by weight: 72.3-80 parts of pure water, 0.01-0.08 parts of probiotics bacterial powder, 0.5-2.5 parts of walnut peptide, konjaku flour
0.01-0.08 parts, 0.5-3 parts of mulberry powder, 0.2-0.4 parts of DL-malic acid, 0.12-0.3 parts of guar gum, potassium sorbate 0.02-
0.08 part, 0.07-0.2 parts of vitamin C, 0.008-0.05 parts of Sucralose, 12-18 parts of blueberry inspissated juice, Cranberry inspissated juice
10-16 parts, 0.062-0.2 parts of edible essence.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910407579.6A CN110074291A (en) | 2019-05-16 | 2019-05-16 | Purposes of the probiotics in the child health care product or drink of preparation strengthen immunity |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910407579.6A CN110074291A (en) | 2019-05-16 | 2019-05-16 | Purposes of the probiotics in the child health care product or drink of preparation strengthen immunity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN110074291A true CN110074291A (en) | 2019-08-02 |
Family
ID=67420513
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910407579.6A Pending CN110074291A (en) | 2019-05-16 | 2019-05-16 | Purposes of the probiotics in the child health care product or drink of preparation strengthen immunity |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110074291A (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623099A (en) * | 2009-04-17 | 2010-01-13 | 黑龙江北奇神高科保健品有限公司 | Blueberry probiotic powder and process method thereof |
| CN107183728A (en) * | 2017-07-12 | 2017-09-22 | 温州市香格里拉食品有限公司 | A kind of probiotics composite powder containing walnut peptide and preparation method thereof |
| CN107637833A (en) * | 2017-09-01 | 2018-01-30 | 山东健康源生物工程有限公司 | A kind of infant's probiotic powder and preparation method thereof |
| CN108041169A (en) * | 2017-11-29 | 2018-05-18 | 上海晨冠乳业有限公司 | A kind of children's solid beverage containing probiotics and prebiotics and preparation method thereof |
| CN109287920A (en) * | 2018-09-14 | 2019-02-01 | 安吉艾格赛思生物科技有限公司 | A kind of solid beverage and preparation method thereof of multicomponent complex and multi-joint probiotics |
-
2019
- 2019-05-16 CN CN201910407579.6A patent/CN110074291A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101623099A (en) * | 2009-04-17 | 2010-01-13 | 黑龙江北奇神高科保健品有限公司 | Blueberry probiotic powder and process method thereof |
| CN107183728A (en) * | 2017-07-12 | 2017-09-22 | 温州市香格里拉食品有限公司 | A kind of probiotics composite powder containing walnut peptide and preparation method thereof |
| CN107637833A (en) * | 2017-09-01 | 2018-01-30 | 山东健康源生物工程有限公司 | A kind of infant's probiotic powder and preparation method thereof |
| CN108041169A (en) * | 2017-11-29 | 2018-05-18 | 上海晨冠乳业有限公司 | A kind of children's solid beverage containing probiotics and prebiotics and preparation method thereof |
| CN109287920A (en) * | 2018-09-14 | 2019-02-01 | 安吉艾格赛思生物科技有限公司 | A kind of solid beverage and preparation method thereof of multicomponent complex and multi-joint probiotics |
Non-Patent Citations (2)
| Title |
|---|
| 朱韶娟等: "复合乳酸菌粉冲剂增强免疫力作用的研究", 《现代食品科技》 * |
| 胡学智: "益生菌的免疫调节作用", 《江苏调味副食品》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Morais et al. | The role of probiotics and prebiotics in pediatric practice | |
| CN109123295A (en) | A kind of probiotics solid beverage and preparation method thereof | |
| US20100166721A1 (en) | Probotic compositions and uses thereof | |
| US20110165127A1 (en) | Dairy-derived probiotic compositions and uses thereof | |
| CN107455744A (en) | A kind of fementative composition ferment and preparation method thereof in vivo | |
| Vandenplas et al. | Probiotics in infectious diarrhoea in children: are they indicated? | |
| CN103476273A (en) | Bifidobacterium bifidum strains for application in gastrointestinal diseases | |
| CN107897381A (en) | A kind of modulation milk powder of adjustment function of intestinal canal containing lactase and preparation method thereof | |
| CN108740251A (en) | A kind of probiotic gel candy and preparation method thereof improving constipation | |
| CN108743851A (en) | A kind of preparation method and compound probiotic powder of compound probiotic powder | |
| CN102665737A (en) | Bifidobacterium longum ATCC BAA-999 (BL999) and weight control | |
| CN113855712B (en) | Composition capable of promoting defecation and application thereof | |
| CN106036911A (en) | Probiotics diet composition and functional food for regulating blood glucose level | |
| CN106172758A (en) | A kind of Yoghourt being effectively improved intestinal microenvironment and preparation method thereof | |
| CN111671079A (en) | Composite probiotic powder composition and preparation method thereof | |
| CN108770974A (en) | A kind of antianaphylactic probiotic gel candy and preparation method thereof | |
| CN100482104C (en) | Process for preparing lactic acid bacteria oral liquor | |
| CN111227261A (en) | Prebiotic composition and application thereof | |
| CN110477105A (en) | A kind of probiotics solid beverage | |
| CN109315769A (en) | It is a kind of for improving the composition and preparation method thereof of human body enteral environment | |
| CN106890317A (en) | A kind of lactase composition and its application | |
| CN106954673A (en) | A kind of dairy products comprising probiotics and preparation method thereof | |
| CN106879739A (en) | A kind of microbial fermentation lactic acid formulation for containing four class viable bacterias and preparation method thereof | |
| Szajewska | Probiotics and prebiotics in pediatrics: where are we now? | |
| CN108936679A (en) | A kind of compound intestinal health health care product |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20190802 |
|
| WD01 | Invention patent application deemed withdrawn after publication |